Oxybutynin reduces sweating in depressed patients treated with sertraline: a double-blind, placebo-controlled, clinical study

BACKGROUND: Selective serotonin reuptake inhibitors are primarily used in the pharmacological treatment of patients experiencing a major depressive disorder. However, one of the common unwanted effects is excessive sweating or hyperhidrosis. Oxybutynin is an anticholinergic medication which reduces...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ghaleiha, Ali, Jahangard, Leila, Sherafat, Zahra, Ahmadpanah, Mohammad, Brand, Serge, Holsboer-Trachsler, Edith, Bajoghli, Hafez, Haghighi, Mohammad
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2012
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3446858/
https://ncbi.nlm.nih.gov/pubmed/23028229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S36329
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller